Company name
Light Chain Bioscience - Novimmune SA
Company profile
Light Chain Bioscience is a clinical-stage biotechnology company advancing therapies based on its proprietary bispecific antibody platform (κλ body)
κλ bodies fully retain the native structure of human IgG leading to low immunogenicity and improved safety in the clinic.
We enable unique mechanisms of action such as safe and selective CD47 targeting and tumor selective CD28 agonism to harness the immune system to treat cancer and other serious indications.
Date, time and room information
Monday, May 4, 15:45 - 16:00, room Montreal
Category
Clinical stage development company
Title of the presentation
Redefining CD47 Immunotherapy through Tumor-Selective Bispecific Antibodies
Speaker information
| Name | Position | Institution |
|---|---|---|
| Walter | Ferlin | Light Chain Bioscience |
